Five muscarinic receptor genes (m1-m5) that encode distinct muscarinic
receptor subtypes have been cloned. Because of their structural homol
ogy and pharmacological similarity, ligand binding probes currently av
ailable do not clearly distinguish among the subtypes. To obtain a cle
ar distribution within the CNS of molecularly defined muscarinic recep
tor subtypes, seven brain regions were examined for the expression of
the respective mRNAs. The most sensitive method for detecting mRNA is
through amplification of the respective cDNAs. Brain regions were obta
ined from male Wistar rats, and total RNA was isolated. The isolates w
ere extensively treated with RNase-free DNase to remove any residual g
enomic DNA. Total RNA (1 mu g) was reverse-transcribed using random pr
imers and reverse transcriptase. The resulting cDNA was amplified usin
g a thermal cycler, and the polymerase chain reaction (PCR)-amplified
products were analyzed by gel electrophoresis containing ethidium brom
ide and visualized with fluorescent illumination. PCR-amplified sample
s were also injected directly onto an HPLC anion exchange column and q
uantified by UV detection. Each of the five muscarinic subtypes was fo
und in every brain region examined. The m1 subtype was most abundant i
n cortex and gradually declined in content caudally to the spinal cord
. The m2 subtype was most abundant in thalamus-hypothalamus and ponsme
dulla. The m4 subtype was found in greatest amount in the striatum, wh
ereas m3 and m5 were expressed consistently throughout the CNS. The co
mbination of RT-PCR and HPLC provides a rapid and sensitive method for
quantifying the expression of mRNA coding for all five muscarinic rec
eptor subtypes derived from the CNS.